Nureca
Nureca Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Nureca
Start SIPNureca Investment Rating
-
Master Rating:
-
Nureca has an operating revenue of Rs. 111.32 Cr. on a trailing 12-month basis. An annual revenue de-growth of -55% needs improvement, Pre-tax margin of -10% needs improvement, ROE of -4% is poor and needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 28% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 16 which is a POOR score indicating inconsistency in earnings, a RS Rating of 12 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 90 indicates it belongs to a poor industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 21 | 28 | 37 | 26 | 41 |
| Operating Expenses Qtr Cr | 25 | 29 | 42 | 32 | 44 |
| Operating Profit Qtr Cr | -4 | -1 | -5 | -5 | -3 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 1 | 1 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | -1 | -1 | -1 |
| Net Profit Qtr Cr | -2 | 0 | -3 | -4 | -1 |
Nureca Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 13
- Bearish Moving Average
- ___
- 3
- 20 Day
- ₹338.54
- 50 Day
- ₹341.74
- 100 Day
- ₹394.48
- 200 Day
- ₹555.72
- 20 Day
- ₹333.68
- 50 Day
- ₹329.92
- 100 Day
- ₹354.79
- 200 Day
- ₹561.91
Nureca Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹399.6 |
| Second Resistance | ₹420.5 |
| Third Resistance | ₹462.3 |
| RSI | 83.87 |
| MFI | 97.46 |
| MACD Single Line | -0.62 |
| MACD | 7.54 |
| Support | |
|---|---|
| First Resistance | ₹336.9 |
| Second Resistance | ₹295.11 |
| Third Resistance | ₹274.2 |
Nureca Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 5,903,203 | 38,547,916 | 6.53 |
| Week | 1,481,337 | 14,887,441 | 10.05 |
| 1 Month | 368,873 | 4,791,664 | 12.99 |
| 6 Month | 377,044 | 5,546,316 | 14.71 |
Nureca Result Highlights
Nureca Synopsis
NSE-Medical-Products
Nureca Ltd is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 111.90 Cr. and Equity Capital is Rs. 10.00 Cr. for the Year ended 31/03/2023. Nureca Ltd. is a Public Limited Listed company incorporated on 02/11/2016 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24304MH2016PLC320868 and registration number is 320868.| Market Cap | 424 |
| Sales | 112 |
| Shares in Float | 0.37 |
| No of funds | 5 |
| Yield | 1 |
| Book Value | 2.17 |
| U/D Vol ratio | 7.9 |
| LTDebt / Equity | |
| Alpha | -0.39 |
| Beta | 0.72 |
Nureca
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 62.98% | 62.98% | 70% | 70% |
| Mutual Funds | 1.35% | |||
| Foreign Portfolio Investors | 0.1% | 0.1% | 1.67% | 12.04% |
| Financial Institutions/ Banks | 0.55% | 3.88% | ||
| Individual Investors | 34.06% | 34.17% | 25.85% | 8.54% |
| Others | 2.86% | 2.75% | 1.93% | 4.19% |
Nureca Management
| Name | Designation |
|---|---|
| Mr. Saurabh Goyal | Chairman & Managing Director |
| Mr. Aryan Goyal | WholeTime Director & CEO |
| Mr. Rajinder Sharma | Whole Time Director |
| Mrs. Charu Singh | Independent Director |
| Mrs. Ruchita Agarwal | Independent Director |
| Mr. Vijay Kumar Sharma | Independent Director |
| Dr. Vikram Chaudhery | Independent Director |
| Mr. Nitin Ravindra Bidikar | Independent Director |
| Dr. Shrikant Uttam Tamhane | Independent Director |
Nureca Forecast
Price Estimates
Nureca FAQs
What is Share Price of Nureca ?
Nureca share price is ₹423 As on 03 June, 2023 | 23:11
What is the Market Cap of Nureca ?
The Market Cap of Nureca is ₹423.6 Cr As on 03 June, 2023 | 23:11
What is the P/E ratio of Nureca ?
The P/E ratio of Nureca is -51.3 As on 03 June, 2023 | 23:11
What is the PB ratio of Nureca ?
The PB ratio of Nureca is 2.2 As on 03 June, 2023 | 23:11